Home > Balance Sheet > GLAXOSMITHKLINE PHARMACEUTICALS

GLAXOSMITHKLINE PHARMACEUTICALS
Net Current Assets

    Back to Balance Sheet
GLAXOSMITHKLINE PHARMACEUTICALS is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
COMMUNITY POLL
for GLAXOSMITHKLINE PHARMACEUTICALS
Please provide your vote to see the results

GLAXOSMITHKLINE PHARMACEUTICALS Last 5 Year Net Current Assets History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Net Current Assets (Including Current Investments) ₹1,827 Cr₹1,505 Cr₹1,273 Cr₹1,168 Cr₹2,009 Cr

What is the latest Net Current Assets ratio of GLAXOSMITHKLINE PHARMACEUTICALS ?

The latest Net Current Assets ratio of GLAXOSMITHKLINE PHARMACEUTICALS is ₹1,827 Cr based on Mar2026 Consolidated results.
Year Net Current Assets
Mar2026₹1,827 Cr
Mar2025₹1,505 Cr
Mar2024₹1,273 Cr
Mar2023₹1,168 Cr
Mar2022₹2,009 Cr

How is Net Current Assets of GLAXOSMITHKLINE PHARMACEUTICALS Trending?

Years Net Current Assets % Change
Mar2026 ₹1,827 Cr
21.42
Mar2025 ₹1,505 Cr
18.16
Mar2024 ₹1,273 Cr
9.04
Mar2023 ₹1,168 Cr
-41.88
Mar2022 ₹2,009 Cr -

Compare Net Current Assets of peers of GLAXOSMITHKLINE PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLAXOSMITHKLINE PHARMACEUTICALS ₹44,687.7 Cr -0.7% 6% 8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹449,228.0 Cr -0.8% 7.3% 7.7% Stock Analytics
DIVIS LABORATORIES ₹293,874.0 Cr -3.3% 21.8% 68.7% Stock Analytics
TORRENT PHARMACEUTICALS ₹176,413.0 Cr -1.7% 1.9% 22.1% Stock Analytics
DR REDDYS LABORATORIES ₹116,604.0 Cr 0.7% 12.4% 12.4% Stock Analytics
CIPLA ₹114,720.0 Cr 0.7% 6.7% -9.4% Stock Analytics


GLAXOSMITHKLINE PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLAXOSMITHKLINE PHARMACEUTICALS

-0.7%

6%

8%

SENSEX

0.2%

9.8%

-2.9%


You may also like the below Video Courses